Keyphrases
Hepatocellular Carcinoma
100%
Liver
83%
Liver Fibrosis
63%
Ischemia-reperfusion Injury
52%
Hepatocyte Growth Factor
45%
Heme oxygenase-1 (HO-1)
42%
Japan
38%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
38%
Liver Injury
38%
Fatty Liver
37%
Matrix Metalloproteinases
35%
Carbon Tetrachloride
35%
Hepatitis B Surface Antigen (HBsAg)
34%
Hepatic Stellate Cells
34%
Nonalcoholic Steatohepatitis
33%
Tumor Necrosis Factor-α
31%
Acute Liver Injury
31%
Prolyl Hydroxylase
29%
Gene Expression
29%
Stellate Cells
28%
Rat Liver
28%
Hepatocytes
27%
Liver Model
27%
Tumor
25%
Type IV Collagen
25%
Advanced Gastric Cancer
24%
Matrix metalloproteinase-2 (MMP-2)
23%
Kupffer Cells
22%
Chemotherapy
22%
Liver Cirrhosis
21%
Matrix metalloproteinase-9 (MMP-9)
21%
Hepatitis B Virus Infection
20%
Interferon-α (IFN-α)
20%
Sorafenib
20%
Transforming Growth Factor-β
20%
Growth-related Genes
20%
Hepatitis C Virus
19%
Advanced Cirrhosis
19%
Advanced Hepatocellular Carcinoma
18%
Inflammatory Cytokines
18%
Apoptosis
18%
High-fat Diet
18%
Human Hepatocellular Carcinoma
18%
Pathological Diagnosis
18%
Immunoelectron
18%
Choline-deficient
18%
Fibrosis
17%
Methionine
17%
Glycyrrhizin
17%
Chronic Hepatitis C
17%
KRAS mutation
17%
Antisense Oligonucleotides
17%
Steatohepatitis
17%
Fulminant Hepatic Failure
17%
Varicella Vaccine
17%
5-fluorouracil (5-FU)
17%
Docetaxel
17%
Percutaneous Radiofrequency Ablation
17%
Sirtuin 1 (SIRT1)
17%
Spatial Distribution
17%
Hepatitis
17%
Hepatoma Cells
17%
Signaling Pathway
16%
Hepatic Fibrosis
16%
Collagen
16%
Young Males
15%
Type I Collagen
15%
Risk Factors
15%
Steatotic Liver
15%
Chronic Hepatitis
14%
Recombinant
14%
Rough Endoplasmic Reticulum
14%
Hepatocyte Apoptosis
14%
Mouse Model
13%
Chemotherapy-induced Diarrhea
13%
Hepatectomy
13%
Nivolumab
13%
Mouse Liver
13%
Chronic Liver Disease
13%
Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA)
13%
Human Hepatocytes
13%
Liver Metastasis
13%
Colorectal Cancer
13%
Overall Survival
12%
Regeneration
12%
Gastric Cancer
12%
Transplantation
12%
Cirrhotic Liver
12%
Chronic Liver Injury
12%
Tumor Growth
12%
Liver Disease
12%
Cell-to-cell
12%
Molecular Hydrogen
12%
Extracellular Matrix Protein 1 (ECM1)
12%
Electroporation
12%
Liver Function
12%
Differential Diagnosis
11%
Human Liver
11%
Adipose Tissue
11%
Index Score
11%
Medicine and Dentistry
Hepatocellular Carcinoma
84%
Liver Injury
53%
Hepatocyte
36%
Liver Cirrhosis
35%
Liver Fibrosis
34%
In Vitro
32%
Carbon Tetrachloride
31%
Hepatic Stellate Cell
31%
Neoplasm
29%
Fatty Liver
28%
Recurrent Disease
27%
Radiofrequency Ablation
26%
Cell Line
25%
Matrix Metalloproteinase
24%
Stellate Cell
24%
Fibrosis
24%
Messenger RNA
24%
Abdominal Cancer
23%
Chemotherapy
23%
Gene Expression
22%
Injury
21%
Tissue Inhibitor of Metalloproteinase 1
21%
Nonalcoholic Fatty Liver
20%
Hepatitis B
19%
Fibrinogen
18%
Collagen Type 1
18%
Interferon
17%
Fulminant Hepatic Failure
17%
Oncogene Ras
17%
Steatohepatitis
17%
Antisense Oligonucleotide
17%
Experimental Fatty Liver
17%
Reperfusion Injury
17%
Pancreatic Cancer Cell Line
17%
Kupffer Cell
17%
Liver Tumor
16%
Macrophage
16%
Methionine
16%
Choline
16%
Extracellular Matrix
15%
Programmed Cell Death
15%
Fibrogenesis
15%
Metalloprotease Inhibitor
15%
Signal Transduction
15%
Gelatinase A
15%
Chronic Hepatitis
14%
Tumor Progression
14%
Metastatic Carcinoma
14%
Chronic Liver Disease
13%
Nivolumab
13%
Liver Metastasis
13%
Hepatic Encephalopathy
13%
Ascites
12%
Heme Oxygenase 1
12%
Gelatinase B
11%
High Fat Food
11%
Low Drug Dose
11%
Inflammatory Cytokine
11%
Differential Diagnosis
11%
Collagen Type 4
11%
Cancer Growth Factor
11%
Endoscopic Ultrasound Guided Fine Needle Biopsy
11%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
11%
Rough Endoplasmic Reticulum
11%
Adenocarcinoma
11%
Magnetic Resonance Imaging
10%
Hepatoma Cell
10%
Hepatitis C
10%
Liver Transplantation
10%
Pancreas Cancer
10%
Scatter Factor
10%
Ferrous Ion
10%
Hepatitis C Virus
10%
Laminin
10%
Diabetes Mellitus
9%
Collagen Type 3
9%
Experimental Liver Fibrosis
9%
Lymphocyte
9%
Liver Regeneration
9%
Partial Hepatectomy
9%
Docetaxel
8%
Stomach Carcinoma
8%
Multiple Myeloma
8%
Diaphragm Hernia
8%
Neutrophil
8%
Angiomyolipoma
8%
Stellate Cell Line
8%
Interstitial Lung Disease
8%
Copurification
8%
Mesenchymal-Epithelial Transition
8%
Pyrophosphate
8%
Telmisartan
8%
Hemochromatosis
8%
Liver Lobectomy
8%
Gemcitabine
8%
Acinic Cell Carcinoma
8%
Piecemeal Necrosis
8%
Dendritic Cell Function
8%
Small-Cell Carcinoma
8%
Ischemia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
83%
Liver Injury
55%
Reperfusion Injury
43%
Scatter Factor
43%
Liver Fibrosis
40%
Nonalcoholic Fatty Liver
39%
Chemotherapy
38%
Matrix Metalloproteinase
34%
Fatty Liver
34%
Heme Oxygenase 1
33%
Injury
33%
Carbon Tetrachloride
27%
Tumor Necrosis Factor
27%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
26%
Experimental Fatty Liver
26%
Liver Cirrhosis
25%
Tissue Inhibitor of Metalloproteinase
24%
Abdominal Cancer
23%
Cytokine
22%
Messenger RNA
22%
Sorafenib
20%
Choline
19%
Neoplasm
18%
Glycyrrhizin
17%
Interferon
17%
Docetaxel
17%
Hepatitis C Virus
17%
Gelatinase A
15%
Cancer Growth Factor
15%
Overall Survival
15%
Disease
14%
Combination Therapy
14%
Hepatitis B Virus
14%
Fibrinogen
14%
Recurrent Disease
14%
Tissue Inhibitor of Metalloproteinase 1
13%
Gelatinase B
13%
Fibrosis
13%
Liver Disease
13%
Diarrhea
13%
Amino Acid
13%
Hepatic Encephalopathy
13%
Infection
13%
Ascites
12%
Collagen Type 1
12%
Collagen Type 4
11%
Hepatitis B
11%
Virus Hepatitis
11%
Toxic Injury
11%
Mitogen Activated Protein Kinase
11%
Methionine
11%
Collagenase 3
11%
Hepatitis C
10%
Tumor Growth
10%
Colitis
10%
Metastasis
10%
Rat Model
10%
Ferrous Ion
10%
Fluorouracil
10%
Fluoropyrimidine
10%
Immune Checkpoint Inhibitor
10%
Transcription Factor Nrf2
10%
Antivirus Agent
10%
Antioxidant
10%
Inflammation
9%
Malignant Neoplasm
9%
Lipopolysaccharide
9%
Collagen Type 3
9%
Cisplatin
9%
Chronic Hepatitis B
9%
Gene Delivery
9%
Immunotherapy
9%
Hepatitis
9%
Ischemia
8%
Syndrome
8%
Nonhodgkin Lymphoma
8%
Hepatitis B Antigen
8%
Chronic Hepatitis C
8%
Bile Duct Carcinoma
8%
Chronic Hepatitis
8%
Tumor Necrosis
8%
Osteomalacia
8%
Adefovir Dipivoxil
8%
Liver Venoocclusive Disease
8%
Prostacyclin
8%
Hepatitis E
8%
Monotherapy
8%
Experimental Mouse
8%
Multiple Myeloma
8%
Mutant Protein
8%
Glyceraldehyde 3 Phosphate Dehydrogenase
8%
Digestive System Cancer
8%
Experimental Liver Fibrosis
8%
Telmisartan
8%
Citrullinemia Type II
8%
Ulcerative Colitis
8%
Metronidazole
8%
Tolvaptan
8%
Peritoneum Metastasis
8%
Carnitine
8%